Last reviewed · How we verify

NCT05742308

The Effect of Laughter Yoga on Hope and School Burnout

Completed NA Last updated 23 February 2023
What this trial tests

NA trial testing Laughter yoga in Laughter Therapy in 60 participants. Completed in 10 June 2022.

Timeline
20 March 2022
Primary endpoint
10 June 2022
10 June 2022

Quick facts

Lead sponsorHacettepe University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment60
Start date20 March 2022
Primary completion10 June 2022
Estimated completion10 June 2022
Sites2 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 13 to 14, any sex, with Laughter Therapy or Laughter Yoga. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to evaluate the effect of laughter yoga on hope and school burnout among secondary school (8th Grade) students. The study hypothesized that laughter yoga would have an effect on hope and school burnout scores among secondary school students

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of Laughter Yoga on School Burnout and Hope Among Secondary School (Eighth Grade) Students: A Parallel Group Randomized Control Trial.
    Kuru Alıcı N, Kalanlar B. · · 2024 · cited 2× · PMID 39555642 · DOI 10.5152/fnjn.2024.23200

Verify or expand the search:

Other trials of Laughter yoga

Trials testing the same drug.

Other recruiting trials for Laughter Therapy

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05742308.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing